[ad_1] A Phase 2 trial of cell therapy for patients with heart failure and reduced ejection fraction suspended registration following a scandal that led to at least one newspaper article withdrawal and …
Read More »Stem cell trial in heart failure 'on pause' after the retraction of the NEJM
